Coronary artery disease (CAD) which might lead to myocardial infarction (MI)

Coronary artery disease (CAD) which might lead to myocardial infarction (MI) is a complex one. recognized in a large pedigree with an autosomal dominant inheritance pattern of myocardial infarction (MI) and CAD (4). The 21-bp deletion in exon 11 co-segregated with the presence or absence of CAD or MI in the family, and was not found in hundreds of settings without documented CAD by angiography (4). Furthermore, this deletion correlated with lack of nuclear translocation and a marked reduction of transcription activity. However, lack of replication has led to controversies regarding the part of MEF2A with respect to CAD (3, 6, 7). Weng recognized the same deletion in an individual who experienced a transient cerebrovascular assault (6, 7). Two of the probands siblings with the same deletion were reported as not having CAD or myocardial infarction, but none of these individuals experienced undergone coronary angiography and only one had stress screening. Beyond the 21-bp deletion, point mutations in exon 6 and 7 were reported to become associated with an increased risk of myocardial infarction, further implicating the association of with coronary disease, and one of these point mutations, Pro297Leu, was independently replicated (3, 8). Although initial studies supported the involvement of variants in the occurence of CAD/MI, these variants were later identified in healthy individuals, thus raising the possibility that they were rare DNA polymorphisms not directly related to the risk for CAD (6). The role of on more than 1700 patients with MI, 2 large SGI-1776 biological activity control populations, and extended families with apparently Mendelian SGI-1776 biological activity inheritance of the disease showed no evidence of an association between gene (CAG)n polymorphism in CAD (14). The (CAG)n tract encodes polyglutamine tandem repeats ((Q)n)in the protein product of the gene. Here, we report results of screening the exon 11 21-bp deletion mutations and the CAG repeat polymorphism within the same exon of the gene in 12 Iranian CAD pedigrees to assess whether an association exists between the genetic variants and SGI-1776 biological activity CAD in these pedigrees. Materials and Methods was screened for mutations by direct sequencing in all 52 patients and 76 controls. The Sanger di-deoxy nucleotide termination protocol was used for sequencing. Exon 11 of and its flanking intronic sequences in all the patients and controls were amplified by the polymerase chain reaction (PCR) and subsequently sequenced (Big Dye kit and the Prism 3700 sequencer; Applied Biosystems, Foster City, CA, USA). Primers used for PCR amplification and sequencing were designed by the Primer 3 software ( bin/primer3/primer3) according to reference sequence (NM_005920.2) (Table 1). Sequences were analyzed through their comparison with the reference sequence (NT_037852.6) using Sequencher 4.8 software (Gene Codes, Ann Arbor, MI, USA). Table 1 Primer sequences used for amplification and sequencing of exon 11 Patients by next generation sequencing in ten patients and ten controls, confirmed absence of the 21-bp deletion in these individuals. However, 31 sequence variations were found in in the DNAs of the Sox18 20 individuals sequenced; 5 of these were SGI-1776 biological activity found only in patients, 2 were found only in controls, and 24 were found in both groups (Table 4). Nineteen of the variations had been previously reported as polymorphisms, and 12 are novel variations. None of the novel variations were positioned within amino acid coding regions, and none were predicted to affect splicing. Five of the previously reported variations were within codons, and four of these affected synonymous changes (p.G443G, p.Q291Q, p.N289N and p.P472P). The only variation that caused an amino acid change (p.P421QQP) was observed in both patients and controls. None of the sequence variations within were associated with CAD status. Table 4 Genetic variants inMEF2Afound by sequencing of 10 Iranian Coronary Artery Disease patients and 10 controls was found to segregate with CAD in a large pedigree, and was claimed as the first CAD causing gene that results in Mendelian inheritance of the disease (4). Among the 93 predicted genes within the identified linked locus, reported in the 2007 Scientific Sessions of the American Heart Association that is positioned, have not been observed (15-17). This is not surprising, because mutations in the Mendelian counterparts of common complex disease traits are often largely.

This entry was posted in Main and tagged , . Bookmark the permalink.